Department of Clinical Sciences, Diabetes and Endocrinology, CRC, Lund University, Malmö, Sweden.
Diabetes Unit, Kamalnayan Bajaj Diabetology Research Centre, King Edward Memorial Hospital and Research Centre, Pune, India.
Diabetologia. 2022 Jan;65(1):65-78. doi: 10.1007/s00125-021-05543-y. Epub 2021 Oct 23.
AIM/HYPOTHESIS: Five subgroups were described in European diabetes patients using a data driven machine learning approach on commonly measured variables. We aimed to test the applicability of this phenotyping in Indian individuals with young-onset type 2 diabetes.
We applied the European-derived centroids to Indian individuals with type 2 diabetes diagnosed before 45 years of age from the WellGen cohort (n = 1612). We also applied de novo k-means clustering to the WellGen cohort to validate the subgroups. We then compared clinical and metabolic-endocrine characteristics and the complication rates between the subgroups. We also compared characteristics of the WellGen subgroups with those of two young European cohorts, ANDIS (n = 962) and DIREVA (n = 420). Subgroups were also assessed in two other Indian cohorts, Ahmedabad (n = 187) and PHENOEINDY-2 (n = 205).
Both Indian and European young-onset type 2 diabetes patients were predominantly classified into severe insulin-deficient (SIDD) and mild obesity-related (MOD) subgroups, while the severe insulin-resistant (SIRD) and mild age-related (MARD) subgroups were rare. In WellGen, SIDD (53%) was more common than MOD (38%), contrary to findings in Europeans (Swedish 26% vs 68%, Finnish 24% vs 71%, respectively). A higher proportion of SIDD compared with MOD was also seen in Ahmedabad (57% vs 33%) and in PHENOEINDY-2 (67% vs 23%). Both in Indians and Europeans, the SIDD subgroup was characterised by insulin deficiency and hyperglycaemia, MOD by obesity, SIRD by severe insulin resistance and MARD by mild metabolic-endocrine disturbances. In WellGen, nephropathy and retinopathy were more prevalent in SIDD compared with MOD while the latter had higher prevalence of neuropathy.
CONCLUSIONS /INTERPRETATION: Our data identified insulin deficiency as the major driver of type 2 diabetes in young Indians, unlike in young European individuals in whom obesity and insulin resistance predominate. Our results provide useful clues to pathophysiological mechanisms and susceptibility to complications in type 2 diabetes in the young Indian population and suggest a need to review management strategies.
目的/假设:使用基于数据的机器学习方法对常见测量变量,在欧洲糖尿病患者中描述了五个亚组。我们旨在检验该表型在印度年轻 2 型糖尿病患者中的适用性。
我们将欧洲衍生的质心应用于来自 WellGen 队列(n=1612)的 45 岁以下诊断为 2 型糖尿病的印度个体。我们还对 WellGen 队列应用了从头 k-均值聚类来验证亚组。然后,我们比较了亚组之间的临床和代谢内分泌特征以及并发症发生率。我们还比较了 WellGen 亚组与两个年轻的欧洲队列(ANDIS,n=962 和 DIREVA,n=420)的特征。还在另外两个印度队列 Ahmedabad(n=187)和 PHENOEINDY-2(n=205)中评估了亚组。
印度和欧洲的年轻 2 型糖尿病患者主要分为严重胰岛素缺乏(SIDD)和轻度肥胖相关(MOD)亚组,而严重胰岛素抵抗(SIRD)和轻度年龄相关(MARD)亚组则很少见。在 WellGen 中,SIDD(53%)比 MOD(38%)更常见,与欧洲人的发现相反(瑞典分别为 26%比 68%,芬兰分别为 24%比 71%)。在 Ahmedabad(57%比 33%)和 PHENOEINDY-2(67%比 23%)中也观察到 SIDD 比例高于 MOD。与 MOD 相比,SIDD 亚组在印度人和欧洲人中均以胰岛素缺乏和高血糖为特征,MOD 以肥胖为特征,SIRD 以严重胰岛素抵抗为特征,MARD 以轻度代谢内分泌紊乱为特征。在 WellGen 中,SIDD 比 MOD 更易发生肾病和视网膜病变,而后者则更易发生神经病变。
结论/解释:我们的数据表明,与年轻的欧洲人不同,胰岛素缺乏是印度年轻 2 型糖尿病的主要驱动因素,而在年轻的欧洲人中,肥胖和胰岛素抵抗则占主导地位。我们的研究结果为 2 型糖尿病在印度年轻人群中的病理生理机制和并发症易感性提供了有用的线索,并提示需要重新审视管理策略。